FVR Järvenpään rokotetutkimusklinikka

Research site

Finland Mannilantie 44, 04400 Jarvenpaa, Finland

1 trial recruiting
Pneumococcal immunisation
Children and adolescents

About Specializations

FVR Järvenpään rokotetutkimusklinikka in Jarvenpaa, Finland specialises in clinical trials of conditions such as Pneumococcal immunisation, and other specialisations. This site conducts important research.

Pneumococcal immunisation

Main research areas of the site

Bacterial Infections and Mycoses

Researchers are studying the pneumococcal vaccine to ensure it is safe for healthy infants and children.

Safety assessment of pediatric vaccines
Immune response profiling in infants and adolescents
Evaluation of expanded pneumococcal coverage

The work is conducted at FVR Järvenpään rokotetutkimusklinikka, a non‑commercial health‑care facility in Finland.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Mannilantie 4404400 JarvenpaaFinland

Open in maps ↗

Recruiting now: 1 trial
Conditions studied: 1

More sites in Jarvenpaa Finland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

2 clinical trials

Pneumococcal immunisation

Recruiting

Safety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease

Registered drugNo placebo

Safety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease

Registered drugNo placebo

Finland

Participants:0–17 years
Substances:PF-07831695
Sponsor:Pfizer Inc.

Contact Research Centre

Pneumococcal immunisation

Not yet recruiting

Safety and immune response of PF-07872412 compared with 20-valent pneumococcal conjugate vaccine for pneumococcal disease in healthy children and adolescents

Registered drugNo placebo

Safety and immune response of PF-07872412 compared with 20-valent pneumococcal conjugate vaccine for pneumococcal disease in healthy children and adolescents

Registered drugNo placebo

Finland

Participants:0–17 years
Substances:PF-07831695
Sponsor:Pfizer Inc.

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites